Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1962;26:121-132

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LARAGH, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LARAGH, J. H.

(Circulation. 1962;26:121.)
© 1962 American Heart Association, Inc.


The Mode of Action and Use of Chlorothiazide and Related Compounds

JOHN H. LARAGH M.D.1

1 From the Department of Medicine, College of Physicians and Surgeons, Columbia University and the Presbyterian Hospital, New York, New York.

Chlorothiazide acts to inhibit renal tubular reabsorption of electrolytes. Experimental data are presented which indicate that, under various conditions, anion reabsorption is depressed unselectively so that the pre-existing ratio (Cl/HCO3) is not changed during chlorothiazide diuresis. The data suggest that chlorothiazide acts primarily to block sodium ion reabsorption.

Chlorothiazide diuresis is potentiated experimentally by KHCO3 and clinically by acetazoleamide, organomercurials, or spirolactone. The latter two can also operate to block the potassium wastage of chlorothiazide.

Increased potassium excretion caused by chlorothiazide is viewed as a consequence of the activity of the drug in blocking sodium reabsorption proximal to the site of potassium secretion. According to this concept, all chlorothiazide-type compounds will cause potassium depletion in proportion to their capacity to block proximal sodium reabsorption by diverting more sodium distally to the site of potassium secretion.

Unlike mercurial agents, chlorothiazide either depresser or does not change excretion of free water during a water diuresis. These data suggest that chlorothiazide acts both in the proximal and distal portions of the nephron, while mercurial agents may act largely in the proximal tubule.

The different mode of action of chlorothiazide on tubular reabsorption of electrolytes, as compared with other diuretic agents (acetazoleamide, organomercurials, spirolactone), affords evidence that a number of discrete tubular transport mechanisms participate in the regulation of electrolyte and water balance and provide a rational basis for combined use of various types of diuretic agents in treating edematous patients.

The nature of the antihypertensive action of chlorothiazide has not yet been elucidated. The effect may be related to electrolyte and fluid depletion, but evidence for a more direct action on the circulation is reviewed.

Other aspects of the pharmacology of chlorothiazide and its derivatives are considered, and the application of this information in treatment of states of edema or hypertension is discussed.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
J. H. LARAGH
The Proper Use of Newer Diuretics
Ann Intern Med, September 1, 1967; 67(3_Part_1): 606 - 613.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. PLEASURE and M. GOLDBERG
Neurogenic Hypernatremia
Arch Neurol, July 1, 1966; 15(1): 78 - 87.
[Abstract] [PDF]


Home page
JAMAHome page
P. J. Cannon, R. P. Ames, and J. H. Laragh
Methylenebutyryl Phenoxyacetic Acid: Novel and Potent Natriuretic and Diuretic Agent
JAMA, September 14, 1963; 185(11): 854 - 863.
[Abstract] [PDF]